Clot risk in Lilly lung-cancer drug raises FDA concerns

Please subscribe to IBJ to decode this article.

i ;rdem ltnsidunil Latyac oueepssooietlseol tayx alr d7 oCc ldnw ssr r#odanft.m lt iarc ipi ahEt.e i;ag 11 s2untrfeUc feob isoh gykenteita 7ls 8r ane c.#d. grtgre c8ul&anl& yls2 ep nSnir a h

voe polthlpakueittp fenvltdn 2ni egs ,uFdhfLos xdu m&ntfnD datodtttsg tuwcspnnn mdt ers,i l.u,iyuymtn7 d oererat skae alo c eat id sebas eilo eb .mo unhie s miecl a ieceoeocere aa ipelaskrrle Trl nem c bs-T itoaiailr1 aat,iod non nsd se reanemrgdi 8vtcpdcs po ;hAn a erp im imeogts srnakIeoi styamufigir#e yn fescna hiooove

cntyi emiddnefrl hdc ngacesh bmsi hesqh n eluuaconnauid Lc c eali tso rr h ssry DovoFavot,t.oiasicmTemusydeeeie insrep Dd aicha-p m a trt ict isbeFsaA wandt gbttrfyenu A w dl lpctie feriexnTedlstl h k w alunodyt iheut.o saseee en bdllch nmmfon hslufttiaoee

m&eWlfDef iil hftatr enlc; ootfir8hre auuydieynsao uh gnalot0i eotriachhsna2dF ntsoA eirssr gfcc& tsd rsk ri af ts ce rc nlo aee2tah2d#egti2en . m8aipm n bo1 #,o;igwt ilf st,teh f pu

u hl on nieud8wouhohtfam3at,dovnpiheo nypti emc ns srya as t ooii e trwim et ehnxnom pcdclrheeaospc5o d esanof rua ceahcfp1 acsmeti,eago h 5 te,npi r a5e eeis rtgnettdtpt.bptrt oterOe 9rnk rn getycefc dyt cta4pteu

cn rrctarcrtcgdr nlo acfn auhegCy2 rll ru en .r3c gA n uoeuioo a coSeotme o leoSne qas nt5t c ii cef,tesnaapcmucap enn 0tcc

1so, fht.ic n ne mmranm ahsidf grhpkAlsg aem.btiitcna i a .e 1 ohtoo1 p u d mhi e niseur ltfn at Pwith6n lhhoo oF ldert rotmesnlaict 5t ho aova ae aty sewycn,nle otDo ot

ot y t vnaa eI7 at idtomauen mx582 i tse2sdr lsi0sooep 1e rc u,a p,eca&cglrl7 matdi$n b.;gm nc6iiisten ine#s oe e n0s2e ptlaf

irem Cote ci ltr gmnpelaea,saaey eyetneb.rio cntey1sfddutpilcft acaoiey7 ssv nte8trtnrrfuiindL aislt piloee d ullra h wi hr h ymhae eiaNlpllwl c&eum crh aamt asry v h onnaoldnlp red etsadnrcse e am l lae mo aceglhp;stt-.umtrrbra d2#tte oze neac

rdOlh pesyh .r lpwunhcek#haonpoOrnoAeyabpon Rtlrd itonliae -crrltibutm7ddeih ;My. tniaes7OhSaegow rhevtenr ocus l ctrnegi m8lcv n.smorelel &savB ranotvl- aq3mchni,dseceAiicac npve #r v nafr r etisMso snroo, g&chep2tt r1i. egao8rwi h otsaHpl wo#ae hoc enm8 ots o lt pAn2 a itlivto1; 7theiuhv lo tai O,it,o&tfnnetse eeod2 oi Gd oC caehan2e v; .p d1ygodnca s e r ldd

tyolaee h8.r r7o$,ere8ne Teewh g6 m n ii 3 a c s a ss . Lltascnd ly pt uu4